author-photo

Masakazu Fukushima

University of Tokushima

225

Papers

6953

Citations

Citation Trend

Filter By

Papers (169) Sort By

Journal Conference Others

A novel intraperitoneal therapy for gastric cancer with DFP‐10825, a unique RNAi therapeutic targeting thymidylate synthase, in a peritoneally disseminated xenograft model

2019 Cancer Medicine
Show All
- Source
- Cite
- Save
Citations (2)
A simplified method for manufacturing RNAi therapeutics for local administration

2019 International Journal of Pharmaceutics
Show All
- Source
- Cite
- Save
Citations (3)
Co-administration of liposomal l-OHP and PEGylated TS shRNA-lipoplex: A novel approach to enhance anti-tumor efficacy and reduce the immunogenic response to RNAi molecules

2017 Journal of Controlled Release
Show All
- Source
- Cite
- Save
Citations (1)
Association between mRNA expression of chemotherapy-related genes and clinicopathological features in colorectal cancer: A large-scale population analysis.

2016 International Journal of Molecular Medicine
Show All
- Source
- Cite
- Save
Citations (8)
Downregulation of thymidylate synthase by RNAi molecules enhances the antitumor effect of pemetrexed in an orthotopic malignant mesothelioma xenograft mouse model.

2016 International Journal of Oncology
Show All
- Source
- Cite
- Save
Citations (14)
Abstracts of Workshop

2013 Human Cell
Show All
- Source
- Cite
- Save
Citations (0)
Platelet-derived endothelial cell growth factor/thymidine phosphorylase inhibitor augments radiotherapeutic efficacy in experimental colorectal cancer

2012 Cancer Letters
Show All
- Source
- Cite
- Save
Citations (15)
The combination of hyperthermia or chemotherapy with gimeracil for effective radiosensitization

2012 Strahlentherapie Und Onkologie
Show All
- Source
- Cite
- Save
Citations (10)
Effects of depletion of dihydropyrimidine dehydrogenase on focus formation and RPA phosphorylation.

2012 Journal of Radiation Research
Show All
- Source
- Cite
- Save
Citations (5)
230 An Entirely Novel Nanoparticle Carrying a Bioactive shRNA Molecule (DFP-10825) Could Be Clinically Effective Against the High Risk Patients with Mesothelioma Relapsed or Refractory After Treatment with Pemetrexed Based Chemotherapy

2012 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (1)